MedPath

Breast Cancer Risk Reduction: A Patient Doctor Intervention

Not Applicable
Completed
Conditions
Breast Cancer
Registration Number
NCT01830933
Lead Sponsor
University of California, San Francisco
Brief Summary

The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1235
Inclusion Criteria
  1. Patient component:

    • Women who visit the General Internal Medicine (GIM) practices at SFGH and UCSF during the study period
    • Between the ages of 40 and 74
    • Self-identify as Asian American, Spanish- and English-speaking Latinas, African American, or White
    • Have no history of breast cancer are eligible to participate.
  2. Physician component: Primary care physicians currently practicing at the GIM clinics at SFGH and UCSF

Exclusion Criteria
  1. Patient component: Women whose physicians object to their participation in the study
  2. Physician component: No exclusion criteria for physicians

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Knowledge of Breast Cancer Risk Factorsone week post-initial visit (approximately one week)

Risk knowledge was assessed using a post-survey. Participants could have scored 0-100 (with 0 meaning no correct answers, and 100 is all correct answers). This outcome was measured through a survey. Breast cancer risk knowledge was based on a series of eight questions in the survey. O

Percentage of Participants Who Reported Discussion of Mammography Screeningup to 14 months

Self reported discussion of mammography with physician.

Percentage of Participants With Correct Perception of Riskbaseline, one week post-initial visit (approximately one week)

This outcome was measured through a survey. Women were asked what they thought about their risk of getting breast cancer was compared to other women of the same age.

Percentage of Participants Who Had a Discussion of Breast Cancer Riskone week post-initial visit (approximately one week)

Self-reported discussion of breast cancer risk with physicians.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

San Francisco General Hospital (SFGH)

🇺🇸

San Francisco, California, United States

University of California, San Francisco Mt. Zion campus

🇺🇸

San Francisco, California, United States

San Francisco General Hospital (SFGH)
🇺🇸San Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.